Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
In Vitro Cancer Diagnostics Market Is Expected To Grow at a CAGR Of 3.9% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
January 13, 2023 13:07 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The Global In-vitro Cancer Diagnostic Market is expected to grow at a CAGR of 3.9% during the forecasting period 2023-2030. Cancer is the growth of...
Global Point-of-Care (POC) Blood Diagnostics Market is set to witness a growth rate of 6% by 2026 – Increasing Occurrence of Cardiovascular & Infectious Diseases
August 16, 2022 09:30 ET
|
Medi-Tech Insights
BRUSSELS, BELGIUM, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Description: Point-of-care (POC) testing entails performing a diagnostic test outside of a laboratory, or near a patient and at the site where...
Global Coagulation Testing Market Anticipated to Garner a Revenue of $3,566.0 Million at a CAGR of 5.9% during the Forecast Period, 2019-2026 - Absolute Report [Pages-105] by Research Dive
June 15, 2021 09:15 ET
|
Research Dive
New York, USA, June 15, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global coagulation testing market is projected to register a revenue of $3,566.0 million at a...
Patient Registry Software Market Size to Reach USD 2.96 Bn by 2027 | Rising Incidence of Chronic Diseases and Increasing Initiatives Related to Value-Based Care will be the Key Factor Driving the Industry Growth, States Emergen Research
January 26, 2021 14:00 ET
|
Emergen Research
Vancouver, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The global patient registry software market is forecast to reach a value of USD 2.96 Billion by 2027, at a rapid and steady CAGR of...
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
December 01, 2020 07:31 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Dec. 01, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has...
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
June 12, 2020 08:00 ET
|
Cue Health Inc.
SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced today that it has received Emergency Use Authorization (“EUA”) from the U.S. Food and...
Sense Appoints John Bishop to its Board of Directors
April 21, 2020 02:00 ET
|
Sense Biodetection
Former Cepheid CEO joins as company launches an accelerated program for the world’s first instrument-free molecular test for COVID-19 CAMBRIDGE and OXFORD, UNITED KINGDOM, April 21, 2020 (GLOBE...
Parallax Announces Immediate Availability Point-of-Care COVID-19 Diagnostic Testing Kits, Personal Protection Equipment (PPE) and Medical Supplies
March 23, 2020 07:00 ET
|
Parallax Health Sciences, Inc.
Company Benefits from Unique Chinese, Hong Kong, Macau Diagnostic Patent Rights, and Closes Deal to Help America Now NEW YORK, NY, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...
OptimizeRx Secures Two Additional Enterprise Clients on Newly Integrated Digital Healthcare Platform
March 11, 2020 08:31 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., March 11, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has secured two additional...
PTS Diagnostics Announces New Retail Point-of-Care Software
January 04, 2018 08:15 ET
|
PTS Diagnostics
PTS Connect ProLink® platform expands connectivity and informatics offerings INDIANAPOLIS, Jan. 04, 2018 (GLOBE NEWSWIRE) -- PTS Diagnostics, a U.S.-based manufacturer of point-of-care biometric...